Saturday, September 5, 2020

#IfWeDoNotRise: Gauri Lankesh’s Legacy Lives On

This article is by

Share this article

Article Contributor(s)

Vanshita Banuana

Article Title

#IfWeDoNotRise: Gauri Lankesh’s Legacy Lives On

Publisher

Global Views 360

Publication Date

September 5, 2020

URL

Image of Gauri Lankesh

Image of Gauri Lankesh | Source: Twitter

In the late evening hours of 5th September, 2017, journalist and activist Gauri Lankesh was unlocking the door to her house after a long day at work. However, she was never destined to set foot inside again, as armed assailants fired seven shots before fleeing, some of which hit Lankesh and led to her death at the scene.

Lankesh was an outspoken critic of right-wing and Hindutva ideologies, and it is widely believed that this was the reason she was targeted. This corresponds with a lot of the arrests that have been made in the case, most of whom—including the people who shot her—were people who belonged to Hindutva groups.

Lankesh was one of three children born to poet and journalist Palya Lankesh who established the weekly Kannada-language Lankesh Patrike. Lankesh followed in her father’s footsteps, starting out in the Times Of India and then working with Sunday magazine for close to a decade. She married, and later divorced, opinion columnist Chidanand Rajghatta, after which she remained single.

Lankesh had been a journalist for 16 years when her father passed away. She and her brother Indrajit initially planned on ceasing the publication of Lankesh Patrike, but was convinced by the publisher to continue. Gauri became the editor, while Indrajit handled the business side of things. However, due to creative and ideological differences, the siblings had a falling out, leading to Gauri establishing her own Kannada weekly called Gauri Lankesh Patrike.

In the last few days before her death, Lankesh and her team were in the process of reshaping her magazine, Gauri Lankesh Patrike. After her death, the staff of Gauri Lankesh Patrike published the last edition of the magazine before shutting it down for a few months.

A year after her death, the staff released the first edition of Nyaya Patha (Way Of Justice), a weekly Kannada-language tabloid. Currently, they also run two websites, Gauri Lankesh News in English and Naanu Gauri in Kannada.

Lankesh’s death was described by the BBC as the most high-profile journalist murdered in recent years. A Karnataka Special Investigation Team (SIT) was formed in 2018 to probe the murder case. The charge sheet for the 18 arrested for their involvement in the case runs thousands of pages long and supposedly provides damning evidence, but similar to cases of other murdered journalists, the case is slow to move forward in court, especially due to the COVID-19 pandemic. Lankesh’s family, along with the families of journalists like M.M. Kalburgi have been appealing to the state government for a special fast-track court to be set up to ensure speedy justice, especially after special measures such as SITs and length investigations to ensure an in-depth probe into the cases.

In light of the third anniversary of Lankesh’s death, activists all over the country are organising a campaign by the name of #IfWeDoNotRise, to speak out against the crackdown on dissenting journalists and activists. Many journalists have been murdered in manners similar to Lankesh and others are arrested under laws like the Unlawful Activities (Prevention) Act, which has been accused of being misused to clamp down on freedom of speech.

Those protesting against rightward shift in governance look up to figures like Gauri Lankesh who paid for their activism with their life, but are also raising their voices to ensure that it doesn’t happen again. Forgetting Lankesh and the circumstances of her death means forgetting the constant threat of Hindutva indoctrination and its violence, which is only increasing under the present ruling dispensation.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More